Ligand validation:4QN9

DXC: (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID

DXC is a Ligand Of Interest in 4QN9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QN9_DXC_A_505	57%	41%	0.186	0.964	0.97	1.32	1	6	2	0	100%	1
4QN9_DXC_B_602	55%	45%	0.183	0.954	0.94	1.19	1	6	2	0	100%	1
4QN9_DXC_A_504	53%	41%	0.19	0.952	0.93	1.34	2	7	2	0	100%	1
4QN9_DXC_A_506	50%	41%	0.184	0.934	0.95	1.32	1	6	0	0	100%	1
4QN9_DXC_B_601	47%	40%	0.216	0.955	0.96	1.36	1	7	1	0	100%	1
4QN9_DXC_B_607	42%	34%	0.229	0.949	1.08	1.51	4	11	1	0	100%	1
4QN9_DXC_B_603	19%	6%	0.336	0.931	1.28	3.81	3	23	2	0	100%	0.5
4QN9_DXC_A_507	16%	7%	0.323	0.894	1.23	3.49	3	20	4	0	100%	0.5
4QN9_DXC_B_608	7%	31%	0.385	0.839	1.12	1.59	2	10	0	0	100%	0.5
4QN9_DXC_B_609	7%	21%	0.389	0.837	1.15	2.11	3	13	1	0	100%	0.5
4QN9_DXC_B_610	1%	20%	0.442	0.606	1	2.37	2	16	1	0	100%	0.5
8PC4_DXC_A_408	44%	59%	0.215	0.945	0.53	1.04	-	1	1	0	100%	1
8P96_DXC_B_601	43%	62%	0.232	0.956	0.57	0.86	-	-	1	0	100%	1
8P90_DXC_B_606	39%	59%	0.241	0.949	0.57	0.99	-	1	0	0	100%	1
6UAD_DXC_A_201	92%	20%	0.067	0.959	1.54	1.82	5	12	0	0	100%	1
4AC9_DXC_C_1477	92%	24%	0.077	0.969	1.66	1.46	6	9	1	0	100%	0.95
4A83_DXC_A_1161	90%	60%	0.068	0.95	0.69	0.83	-	1	4	0	100%	1
1OS6_DXC_A_75	84%	17%	0.079	0.939	2.14	1.51	13	9	2	0	100%	1
4HAJ_DXC_A_75	81%	47%	0.1	0.952	0.97	1.08	1	4	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.